Additionally, several studies indicate that CSF cannot reliably differentiate AD patients from patients with other forms of dementia due to the overlapping levels of Aβ1-42, T-tau, and p-tau181 [55,56]. The gene discussed is MAPT; the disease is Alzheimer disease.